330 related articles for article (PubMed ID: 18728938)
61. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
Zhu P; Ye Z; Guo D; Xiong Z; Huang S; Guo J; Zhang W; Polli JE; Zhou H; Li Q; Shu Y
Pharm Res; 2018 Oct; 35(12):243. PubMed ID: 30361780
[TBL] [Abstract][Full Text] [Related]
62. Metformin transport by renal basolateral organic cation transporter hOCT2.
Kimura N; Okuda M; Inui K
Pharm Res; 2005 Feb; 22(2):255-9. PubMed ID: 15783073
[TBL] [Abstract][Full Text] [Related]
63. Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity.
Gai Z; Visentin M; Hiller C; Krajnc E; Li T; Zhen J; Kullak-Ublick GA
Antimicrob Agents Chemother; 2016 Sep; 60(9):5573-80. PubMed ID: 27401566
[TBL] [Abstract][Full Text] [Related]
64. Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+.
Thévenod F; Ciarimboli G; Leistner M; Wolff NA; Lee WK; Schatz I; Keller T; Al-Monajjed R; Gorboulev V; Koepsell H
Mol Pharm; 2013 Aug; 10(8):3045-56. PubMed ID: 23763587
[TBL] [Abstract][Full Text] [Related]
65. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
Tarasova L; Kalnina I; Geldnere K; Bumbure A; Ritenberga R; Nikitina-Zake L; Fridmanis D; Vaivade I; Pirags V; Klovins J
Pharmacogenet Genomics; 2012 Sep; 22(9):659-66. PubMed ID: 22735389
[TBL] [Abstract][Full Text] [Related]
66. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.
Leabman MK; Huang CC; Kawamoto M; Johns SJ; Stryke D; Ferrin TE; DeYoung J; Taylor T; Clark AG; Herskowitz I; Giacomini KM;
Pharmacogenetics; 2002 Jul; 12(5):395-405. PubMed ID: 12142729
[TBL] [Abstract][Full Text] [Related]
67. Interaction of Cisplatin with the human organic cation transporter 2.
Filipski KK; Loos WJ; Verweij J; Sparreboom A
Clin Cancer Res; 2008 Jun; 14(12):3875-80. PubMed ID: 18559608
[TBL] [Abstract][Full Text] [Related]
68. Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
Hacker K; Maas R; Kornhuber J; Fromm MF; Zolk O
PLoS One; 2015; 10(9):e0136451. PubMed ID: 26327616
[TBL] [Abstract][Full Text] [Related]
69. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
Higgins JW; Bedwell DW; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2012 Jun; 40(6):1170-7. PubMed ID: 22407892
[TBL] [Abstract][Full Text] [Related]
70. Genetic variation in organic cation transporters and considerations in drug development.
Varma MVS
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):149-164. PubMed ID: 37070463
[TBL] [Abstract][Full Text] [Related]
71. Genetic and Epigenetic Regulation of Organic Cation Transporters.
Kölz C; Schaeffeler E; Schwab M; Nies AT
Handb Exp Pharmacol; 2021; 266():81-100. PubMed ID: 33674913
[TBL] [Abstract][Full Text] [Related]
72. Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in
Kuehne A; Floerl S; Hagos Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555439
[TBL] [Abstract][Full Text] [Related]
73. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.
Lepist EI; Zhang X; Hao J; Huang J; Kosaka A; Birkus G; Murray BP; Bannister R; Cihlar T; Huang Y; Ray AS
Kidney Int; 2014 Aug; 86(2):350-7. PubMed ID: 24646860
[TBL] [Abstract][Full Text] [Related]
74. Pregnancy Increases the Renal Secretion of N
Bergagnini-Kolev MC; Hebert MF; Easterling TR; Lin YS
Drug Metab Dispos; 2017 Mar; 45(3):325-329. PubMed ID: 28069720
[TBL] [Abstract][Full Text] [Related]
75. Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2.
Sandoval PJ; Morales M; Secomb TW; Wright SH
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F720-F734. PubMed ID: 31313952
[TBL] [Abstract][Full Text] [Related]
76. Fenofibrate down-regulates renal OCT2-mediated organic cation transport via PPARα-independent pathways.
Asavapanumas N; Kittayaruksakul S; Meetam P; Muanprasat C; Chatsudthipong V; Soodvilai S
Drug Metab Pharmacokinet; 2012; 27(5):513-9. PubMed ID: 22473497
[TBL] [Abstract][Full Text] [Related]
77. Interaction of six protoberberine alkaloids with human organic cation transporters 1, 2 and 3.
Li L; Sun S; Weng Y; Song F; Zhou S; Bai M; Zhou H; Zeng S; Jiang H
Xenobiotica; 2016; 46(2):175-83. PubMed ID: 26134304
[TBL] [Abstract][Full Text] [Related]
78. Functional map of TEA transport activity in isolated rabbit renal proximal tubules.
Wright SH; Evans KK; Zhang X; Cherrington NJ; Sitar DS; Dantzler WH
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F442-51. PubMed ID: 15126247
[TBL] [Abstract][Full Text] [Related]
79. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium.
Lips KS; Volk C; Schmitt BM; Pfeil U; Arndt P; Miska D; Ermert L; Kummer W; Koepsell H
Am J Respir Cell Mol Biol; 2005 Jul; 33(1):79-88. PubMed ID: 15817714
[TBL] [Abstract][Full Text] [Related]
80. Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol.
Te Brake LH; van den Heuvel JJ; Buaben AO; van Crevel R; Bilos A; Russel FG; Aarnoutse RE; Koenderink JB
Antimicrob Agents Chemother; 2016 Dec; 60(12):7105-7114. PubMed ID: 27645247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
